Clinical Trial Update: Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, tolerance, pharmacokinetics and activity of HE3286 in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HE3286

Snippet

Sponsor: Harbor Therapeutics | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED